EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CLSD: Clearside Biomedical Inc

19 Nov 25 12:00
LAST:

3.010

CHANGE:
 0.06		OPEN:
3.030		HIGH:
3.050		ASK:
6.770		VOLUME:
23.9K
CHG(%):
1.95		PREV:
3.070		LOW:
2.840		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Nov 253.0303.0502.8403.01023.9K
18 Nov 253.3103.4353.0503.07031.3K
17 Nov 253.6303.7503.3303.34046.7K
14 Nov 253.6504.0003.6003.82044.0K
13 Nov 253.7703.9803.6473.69036.3K
12 Nov 254.2604.2603.7513.83059.9K
11 Nov 253.6803.9153.6603.79531.4K
10 Nov 253.7803.9083.6003.68064.2K
07 Nov 253.9603.9603.7003.72076.7K
06 Nov 254.0004.0443.8104.02022.9K

PROFILE

Name:Clearside Biomedical Inc
About:Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Sector:Healthcare
Industry:Biotechnology
Address:900 North Point Parkway, Alpharetta, GA, United States, 30005
Website:https://clearsidebio.com
CUSIP:185063104
CIK:0001539029
ISIN:US1850631045
FIGI:BBG002D4D4X3
LEI:529900GQSUZO5HQ9DS29

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.58 
Forward P/E:-8.08 
PEG Ratio:0.00 
Price to Sales:5.08 
Price to Book:-0.44 
Profit Margin:0.91 
Operating Margin:-7.25 
Return on Assets:-0.55 
Return on Equity:0.88 
EPS Ratio:-5.40 
Revenue:4.17M 
Shares:5.23M 
Market Cap:15.75M 

TECHNICAL INDICATORS

MA5:3.3912.5%
MA10:3.6019.5%
MA20:3.7424.3%
MA50:3.7624.9%
MA100:2.1341.2%
MA200:1.50100.3%
RSI14:35.93 
WPR14:-100.00 
MTM14:-1.06
ROC14:-0.26 
ATR:0.36 
Week High:4.2641.5%
Week Low:2.846.0%
Month High:4.2641.5%
Month Low:2.84100.3%
Year High:4.5751.9%
Year Low:0.29930.8%
Volatility:65.13 

RECENT SPLITS

Date Ratio
15 Sep 20251-15